BLFS Q2 2020 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$890M

Q2 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$10M+48.0% YoY

Gross Profit

$5M54.6% margin

Operating Income

$44,0000.4% margin

Net Income

-$16M-165.1% margin

EPS (Diluted)

$-0.70

QoQ Revenue Growth

-18.4%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$114M

Total Liabilities

$8M

Stockholders' Equity

$106M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+48.0%
Gross Profit	$5M	$5M	+14.3%
Operating Income	$44,000	$919,000	-95.2%
Net Income	-$16M	$838,000	-2054.7%

Revenue Segments

Product

$9M96%

Rental Revenue

$431,0004%